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Abstract
Objective To assess the effectiveness of enhanced communication
therapy in the first four months after stroke compared with an attention
control (unstructured social contact).
Design Externally randomised, pragmatic, parallel, superiority trial with
blinded outcome assessment.
Setting Twelve UK hospital and community stroke services.
Participants 170 adults (mean age 70 years) randomised within two
weeks of admission to hospital with stroke (December 2006 to January
2010) whom speech and language therapists deemed eligible, and 135
carers.
Interventions Enhanced, agreed best practice, communication therapy
specific to aphasia or dysarthria, offered by speech and language
therapists according to participants’ needs for up to four months, with
continuity from hospital to community. Comparison was with similarly
resourced social contact (without communication therapy) from employed
visitors.
Outcome measures Primary outcome was blinded, functional
communicative ability at six months on the Therapy Outcome Measure
(TOM) activity subscale. Secondary outcomes (unblinded, six months):
participants’ perceptions on the Communication Outcomes After Stroke
scale (COAST); carers’ perceptions of participants from part of the Carer
COAST; carers’ wellbeing on Carers of Older People in Europe Index
and quality of life items from Carer COAST; and serious adverse events.
Results Therapist and visitor contact both had good uptake from service
users. An average 22 contacts (intervention or control) over 13 weeks
were accepted by users. Impairment focused therapy was the approach
most often used by the speech and language therapists. Visitors most
often provided general conversation. In total, 81/85 of the intervention
group and 72/85 of the control group completed the primary outcome
measure. Both groups improved on the TOM activity subscale. The
estimated six months group difference was not statistically significant,
with 0.25 (95% CI –0.19 to 0.69) points in favour of therapy. Sensitivity
analyses that adjusted for chance baseline imbalance further reduced
this difference. Per protocol analyses rejected a possible dilution of
treatment effect from controls declining their allocation and receiving
usual care. There was no added benefit of therapy on secondary outcome
measures, subgroup analyses (such as aphasia), or serious adverse
events, although the latter were less common after intervention (odds
ratio 0.42 (95% CI 0.16 to 1.1)).
Conclusions Communication therapy had no added benefit beyond
that from everyday communication in the first four months after stroke.
Future research should evaluate reorganised services that support
functional communication practice early in the stroke pathway.
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Introduction
The UKNational Audit Office recently estimated that the direct
care cost for people with stroke was “at least £3 billion
annually,” with around a third of stroke survivors experiencing
lifelong disabilities.1 Randomised controlled trials and
systematic reviews have shown the effectiveness of specialist
stroke units.2 As stroke units are almost universally provided,3 4
there is a need to explore the components of the “black box” of
care.5 Speech and language therapy is one such component, and
it includes a variety of approaches in clinical practice.6 7 The
prevalence of persisting difficulties with speech (dysarthria)
and language (aphasia) is 30 to 50 per 100 000 population six
months after stroke.8 These communication difficulties restrict
independence and social participation, and negatively affect
informal care givers.9-11
In the draft clinical guideline on stroke rehabilitation from the
National Institute for Health and Clinical Excellence (NICE)
(revision due 2012), speech and language therapy for people
with aphasia was a key priority, although the timing, intensity,
and type of therapy were not specified.12 Given that stroke can
result in lifelong disability, commissioners need to know at what
point in the stroke pathway speech and language therapy for
aphasia is recommended. Despite a firm consensus that speech
and language therapy is beneficial,6 7 13 clinical effectiveness
remains unknown, and no reports from randomised trials have
mentioned cost effectiveness.14 Cochrane reviews and recent
guidelines highlight the absence of a single randomised
controlled trial of treatments for dysarthria,6 15 and the 30 trials
in the aphasia review leave considerable uncertainty.16 The
review’s tentative conclusion reports “some indication” of
effectiveness with speech and language therapy.16 A recently
published update that includes the current study examines
whether speech and language therapy is better than no therapy
at improving functional communication (see our discussion).17
It then examines whether this remains when therapy is compared
with “social support or stimulation” (such as art, dance, and
informal unstructured communicative interactions).
The ACT NoW study (Assessing Communication Therapy in
the North West)18 was commissioned and funded by the UK’s
NIHR Health Technology Assessment Programme. It used a
mixed methods approach (randomised controlled trial and
qualitative study) to examine the effectiveness, cost
effectiveness, and service users’ views and uptake of a well
resourced, flexible intervention offered by speech and language
therapists in the first four months after stroke compared with
an equivalent amount of contact but not therapy provided by
“visitors” (employees not volunteers). The comparison examines
whether speech and language therapy provides added benefit
beyond that likely from regular attention. This paper covers
only the results of the randomised controlled trial. Detailed
reports of the methods, intervention, control arm, health
economic evaluation, and qualitative study have been
published.18 19
Methods
Setting
This multicentre study recruited from 12 English sites from
December 2006 to January 2010. Sites were NHS hospitals that
admitted adults with acute stroke . All had a speech and language
therapy service with expertise in aphasia and dysarthria, and
they agreed to reorganise their service to provide continuity of
care from inpatient to community setting and to work to a
consensus based intervention.
Participants
Adults admitted to hospital with a stroke were eligible for
inclusion if they had impaired communication due to aphasia
or dysarthria, were considered by a speech and language
therapist as likely to benefit from this intervention, and gave
informed consent (or proxy consent by carers). The intention
was to be as inclusive as possible since the intervention was a
flexible, enhanced version of current best practice and intensity
could be modified to individual need.
Exclusion criteria were based on practical resource limitations
such as the participant living outside the area served or being
unable to communicate in the English language (therapists
believed that translation or interpretation services were
inappropriate for aphasia). Therapists also excluded people for
whom intervention was deemed unsuitable—for example, those
receiving end of life care or with pre-existing learning
disabilities or dementia likely to prevent benefits from therapy,
subarachnoid haemorrhage, or serious medical conditions (such
as terminal disease); patients unable to complete the eligibility
screening after three attempts; and patients whose
communication problems resolved or were likely to resolve
without intervention.
Procedure
Initially, all stroke admissions to hospital were screened by
speech and language therapists to determine eligibility.
However, this proved unnecessary, and (fromApril 2008) speech
and language therapists screened only those with suspected
communication problems to confirm the presence and
persistence of communication problems, provide a differential
diagnosis (aphasia, dysarthria, or both), determine the severity
of the communication problem, and rule out non-obvious
exclusion criteria. They used the Frenchay Aphasia Screening
Test (FAST),20 or informal assessment if the communication
problemswere too severe, and the impairment and activity scales
of the Therapy Outcome Measure (TOM).21 Dysarthria was
diagnosed and its severity determined by a TOM rating based
on the speech sample from the FAST picture description task
and conversation. The presence or absence of dysphagia
(swallowing) was also diagnosed. Apraxia of speechwas outside
the remit of this study.
Before randomisation, research assistants also rated patients on
the 10 item Modified Barthel Index22 with the help of the
multidisciplinary team. The Barthel Index gives a score out of
20 and indicates severity of overall disability (beyond
communication). Since the communication impairment was
specifically assessed (TOM), no other stroke severity measures
were required.
Consent
Before randomisation of eligible patients, the speech and
language therapists provided them with an “aphasia friendly”
leaflet about their diagnosis and asked if they would like to meet
a research assistant to discuss the study. The multidisciplinary
team was also alerted to the diagnosis. Speech and language
therapists did not provide further communication support to
participants, their families, or the multidisciplinary team until
after randomisation. Research assistants immediately met
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potential participants to provide study information. Participants
were given 24 hours to allow discussion with their family. We
used aphasia friendly, accessible information materials
developed in collaboration with our Research User Group
partners.18 23When necessary, proxy consent was requested, and
research assistants later gave regular opportunities for
participants to directly provide or withdraw their consent.
Randomisation
To ensure concealment of allocation, randomisation was by an
external, independent, web based randomisation service from
a trials unit activated by research staff. Randomisation was
stratified by the severity of communication impairment and
recruiting site. Stratification by diagnosis was also requested
(aphasia only, dysarthria only, or both), but during data checks
after study completion it became clear this had not occurred.
Participants were randomised using a 1:1 allocation ratio and
randomly permuted blocks.
Intervention
The speech and language therapy was an agreed, best practice,
flexible intervention developed by speech and language
therapists for delivery early after stroke in usual care settings
but better resourced than standard practice at most sites.18 In
this study “early” refers to the acute to post-acute period of the
stroke pathway (the first four months) and is used to distinguish
this clinical population from those with chronic aphasia or
dysathria. This allowed therapy to start as soon as clinically
indicated and, if deemed appropriate, up to three contacts per
week for up to 16 weeks, following participants along their
stroke pathway. Start date, duration, and frequency of therapy
varied within and between participants, as determined by each
therapist’s clinical judgment and agreement with the participant
about what was appropriate. This was not a “one size fits all”
intervention, and these levels of therapy were not prescriptions
but were fixed upper limits. Although well resourced, this study
was not intended as a trial of different levels of intensity.
A manual was developed by the therapists setting out specific
components of the intervention and service delivery, and can
be described as a set of best practice guidelines and a
compendium of resources. There were six core components of
the intervention (see box). Adherence was ensured by an agreed
coding system for all contacts and by employing a part time
therapymonitor, an experienced speech and language therapist.
Therapists attended regular facilitated peer group meetings
where sites presented data on eligibility decisions and descriptive
single case therapy. The therapy monitor visited sites to observe
delivery and inspect the coded data.
Control
A similar frequency and amount of social contact was offered
to those in the control group by employed visitors (not therapists
or volunteers). Visitors had excellent social skills and general
competency and were trained to deliver social attention absent
of any intuitive form of communication therapy or strategy.
They followed a short manual allowing everyday activities (such
as conversation, television, music), but visits were mostly led
by participants. Visitors were monitored to ensure adherence,
including visits from the part time visitor monitor, who selected
and trained visitors, observed their contact with participants,
inspected the coded data from each contact, facilitated group
supervisory meetings of visitors, and provided one to one
support for visitors.
Objectives and outcomes
The randomised controlled trial aimed to evaluate the clinical
effectiveness of the communication intervention compared with
the control social contact six months after entry to the study
from the perspective of different stakeholders:
• Therapists’ ratings of participants’ functional
communication (primary outcome)
• Participants’ self reported functional communication and
quality of life
• Carers’ perceptions of participants’ functional
communication
• Carers’ own wellbeing
• Carers’ quality of life
• Adverse events.
For the primary outcome, a semi-structured conversation
between each participant and an unfamiliar communication
partner (study research assistant) trained in communication
supportive techniques was videotaped. An independent speech
and language therapist, blinded to treatment allocation and not
involved in treating the study participants, rated functional
communication on the communication activity scale of the
Therapy Outcome Measure (TOM). Despite its ecological
validity, conversation between a participant and a familiar
partner was not used as an outcome because of the difficulties
in standardising the content, amount, and support provided. The
chosen method (unfamiliar partner plus blinded rating of
videotapes) has demonstrated validity and reliability.24
Secondary outcomes were:
Participants’ perception of their functional communication
and quality of life—Based on the validated 20 item
Communication Outcomes After Stroke (COAST) scale,25
which covers both understanding and expression in a range
of communication situations, including five items on quality
of life. The score is converted to a percentage, and higher
scores indicate better outcomes.
Carers’ perceptions of participants’ functional
communication—Based on the relevant 15 questions on the
validated Carer COAST scale.26Higher scores indicate better
outcomes.
Carers’ wellbeing—Based on the 15 item Carers of Older
People in Europe (COPE) Index.27 There are three subscales:
negative impact (a high score is a poor outcome as it
indicates stress), positive impact, and quality of support (high
scores are good outcomes as they indicate satisfaction and
support).
Carers’ quality of life as affected by participants’
communication problems—Assessed with the relevant five
questions fromCarer COAST.26Higher scores indicate better
outcomes.
Adverse events—Death, subsequent stroke, events leading
to increased hospital stay or readmission to hospital.
A qualitative study was prospectively nested within the
randomised controlled trial to support the interpretation of the
trial findings in a way that would help commissioning decisions.
Qualitative interviews with participants from both arms of the
trial provided rich detail on service users’ perceptions and their
views on the impact of early regular contact and are reported
elsewhere.18 19
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Core components of the intervention
1. Assessment—Initial and ongoing, standardised, functional, case history, goal setting
2. Information provision—Communication problem, strategies or equipment to assist communication, intervention plan, therapist opinion
of progress, available information resources and support networks
3. Provision of communication materials—Communication book for recording activities, an “alternative and augmentative communication
device” if required
4. Carer contact—Discussion and provision of information, observation and participation in therapy, conversation training for patient’s
partner, preparation for the end of the research intervention
5. Indirect contact—Written descriptions of needs, abilities, and strengths; discussions with clinical teams; goal planning with
multidisciplinary team
6. Direct contact—Therapy to improve language skills at all levels of the World Health Organisation ICF model: Impairment (improving
language skills), Activity (compensatory strategies), Participation (developing confidence, accessible information)
Blinding
In most rehabilitation trials it is impractical and unacceptable
to blind participants and those delivering the intervention to the
allocation group. We endeavoured to blind the research
assistants who collected the outcome data (password protected
data related to allocation, participants asked not to mention
allocation when visited). The risk of bias for the primary
outcome was minimised by using expert speech and language
therapists who did not know the participants and were blinded
to allocation to rate the videotaped structured conversation,
although the therapists may have seen communication aids in
use. We felt strongly that participants’ and carers’ reported
outcome measures should be included as secondary outcomes
although they could not be blinded.
Statistical analysis
The primary analysis used regression methods to estimate group
differences in outcomes at six months after adjustment for the
intended stratification criteria (site, diagnostic group, and
baseline severity of communication impairment on the Therapy
Outcome Measure). The adverse event rates were compared
without adjustment as they were not anticipated to be sufficiently
common to allow multifactorial analysis.
Analyses included all participants assigned to their allocation
group regardless of adherence to protocol—a complete case
analysis under the “intention to treat” approach. Participants
who were lost to follow-up or declined assessment were
excluded. Those known to have died were included as having
the worst possible outcome (no functional communication on
the primary outcome). No other imputation was undertaken.
For outcomes assessed with COAST and Carer COAST, we
compared valid assessments (that is, those with at least 90% of
applicable items answered). No adjustment took place where
responses between participant and carer might be construed as
incompatible, as the instruments were designed to respect the
individual’s self perception.
Sensitivity analysis was used to re-analyse the primary outcome
data in several ways to assess how robust conclusions were to
the choice of approach. Non-adjustment for intended
stratification criteria, allowance for possible therapist effects,
omission of people who had died, and per protocol analyses
were all considered. The exact choice of such sensitivity
analyses was inevitably data driven to some extent. For example,
if primary analysis suggested a group difference the robustness
of this conclusion needed to be examined (for example,
allowance for possible therapist effect). Conversely, if primary
analysis did not suggest a group difference the sensitivity
analysis would focus on approaches that might identify possible
explanations (such as per protocol analysis). We conducted
pre-planned subgroup analysis of type of communication
problem (aphasia or dysarthria) and of severity.
All statistical analyses were undertaken in STATA (version
10.1).
Sample size determination
The original protocol proposed a total sample size of 300
participants for 90% power to detect a difference of 0.5 points
on the primary outcome of the Therapy OutcomeMeasure. The
target effect size of 0.5 on the Therapy Outcome Measure was
chosen as it is the smallest measurable difference on the scale.
This calculation allowed for differential clustering between the
two arms due to different numbers of therapists and visitors,
with intra-cluster correlation coefficient of 0.05 in each arm.
Recruitment was slower than anticipated, leading to revision of
the target. The observed standard deviation of the primary
outcome for the first 43 recruited participants, adjusted as for
primary analysis, was 1.1 points. The initial plan to incorporate
therapist effects in the primary analysis was dropped as there
was insufficient power to examine these potential effects and
the independent Steering Committee considered an intra-cluster
correlation coefficient of 0 to be a more reasonable assumption
given our confidence in our monitoring system that ensured
therapists adhered to the therapy manual. This led to
recalculation of a target sample size of 170 participants to give
80% power at the 5% significance level to detect a difference
of 0.5 points, allowing for approximately 10% loss to follow-up.
Interim analyses and stopping guidelines
No formal stopping rule was applied to interim analyses reported
to the Data Monitoring and Ethics Committee. The videotapes
for assessment of the primary outcome data were stored for
distribution in batches. This precluded early stopping as the
primary outcome remained largely unmeasured at the time of
the committee meetings. Consequently no adjustments were
made to the significance levels or confidence intervals in
presented analyses.
Participant withdrawal criteria
No specific withdrawal criteria were defined for the study.
Participants were able to withdraw their consent and stop their
allocated intervention prematurely. In these cases they could
choose to enter standard services for speech and language
therapy at their site. Regardless of this potential protocol
deviation, research assistants attempted to collect outcome data
for all participants.
Given that participants were assessed for eligibility soon after
stroke admission, specific exclusion criteria might come to light
after randomisation. In these cases, the independent Data
Monitoring and Ethics Committee was consulted as to the
appropriateness of the participant continuing in the trial.
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Results
Of the 389 patients who were eligible and received study
information, 170 (44%) consented to enter the randomised
controlled trial (fig 1⇓). Eighty five people were randomised to
each group (with 72 from the control group and 81 from the
intervention group included in primary analysis). The low
eligibility rate (21% of all admissions or those with a suspected
hyperacute communication problem)was scrutinised throughout
to ensure it was a valid reflection of speech and language
therapists’ usual decision making. The main reason therapists
excluded people after screening was due to false positives: in
43% of cases (690/1632) communication problems had resolved
or were too mild to require intervention. In contrast, fewer than
4% (59/1632) were excluded because their communication
problem was too severe. Participants’ general health problems,
including stroke severity and severe cognitive impairments,
accounted for another 43% of exclusions (694/1632).
The sample had good external validity, as those who consented
were similar in their measured characteristics to those who
declined (table 1⇓). The latter seemed to have slightly less severe
communication impairment and, conversely, slightly more
restrictions at the activity level of measurement, although there
were missing data from those who declined. There was a good
age range within this predictably older clinical population, most
of whom had aphasia (alone or with dysarthria), and around
half had impaired swallowing. Screening and recruitment
procedures moved swiftly. The median time from stroke
admission to randomisation was 12 days. Of course, the speech
and language therapists had first contact with potential
participants earlier (pre-randomisation determination of
diagnosis and severity, etc) at a median of five days after
admission.
Randomisation achieved balance between groups on the
stratification factors and several other demographic measures
(table 2⇓). Ethnicity was undisclosed in two cases but otherwise
did not differ between groups, with 98% of the overall sample
described as white. Socioeconomic status was not collected. On
average the control group was slightly more severely affected
than the intervention group in terms of activity level
communication, dysphagia, and activities of daily living. Most
participants (79%) had an identified carer who was willing to
complete outcome measures. Most carers who took part were
female family members in the same household, not in paid
employment, and were younger than the stroke participants
(mean age 56 years (range 21–80)).
Treatment fidelity and participant follow-up
One participant from each group was withdrawn after
randomisation on the advice of Data Monitoring and Ethics
Committee. Information came to light that questioned the
validity of one participant’s consent, and proxy consent was
declined. The other lived out of area and could not be treated
once discharged.
Protocol violation was more common in the control group. Of
the 72 participants who completed primary outcome assessment,
18 (25%) received some speech and language therapy (average
of 3 hours) before assessment. In the intervention group two
out of 81 participants (2%) received some non-study speech
and language therapy. Analysis of factors associated with study
completion without protocol violation (that is, predictive of
inclusion within the per protocol analysis) suggested that
younger participants with more disabled communication were
more likely to breach protocol. Sensitivity analyses therefore
accounted for these factors as well as the baseline difference in
stroke severity (fig 2⇓) when comparing the per protocol groups.
Eight participants died, and 12 declined follow-up in the control
group, while four died and three declined follow-up in the
intervention group. The median (interquartile range) time to
outcome assessment for the remaining participants was around
the intended six month point (180 (169–182) days).
Intervention and control contacts
Data on the timing, amount, and content of the intervention or
control contacts delivered to each arm are briefly summarised
below as they are described in detail elsewhere.18
Intervention—Speech and language therapy was delivered as
intended, flexibly tailored to individual need and started on
average two weeks after stroke. It involved an average of 22
contacts (18 hours) over 13 weeks, in both hospital and
community settings. Because of practical considerations, therapy
was always delivered on a one to one basis. Seventy three (87%)
participants received therapy led by a senior therapist, and 42%
of all contacts were made by senior therapists. The actual
delivery of the six core components (see text box) is summarised
in table 3⇓, which shows that every therapy participant received
further assessment and direct contact. Table 4⇓ breaks down
the “direct contact” component and shows that 93% of
participants received impairment focused therapy. In addition
to this “head count” analysis, which essentially shows whether
a person received a component, it is useful to explore which
components were used most often. This showed that 53% of
activities were direct contact, 15%were carer contact, 14%were
assessment, 11% indirect contact, 8% information provision,
and 3% the provision of communication materials (difficulty
coding information provision means the total slightly
exceeds100%). When the most common therapy component,
direct contact, is broken down into specific therapy approaches,
impairment focused therapy accounted for half of the direct
contact activity (and almost a quarter of activity overall).
Control—The control social contact was successfully delivered.
Our feasibility study found that using volunteers to deliver the
attention control was impractical and, counterintuitively, very
expensive.18 Therefore, part time visitors were employed (not
volunteers) throughout the main randomised controlled trial.
There were seven women and two men, aged 26–61 (mean 48)
years. Some had taken early retirement, others cared for young
children. Their work experience was at varying levels of
seniority from a receptionist to a retired head teacher. Five had
degree level education. All had well developed social skills and
were natural communicators capable of expressing warmth and
empathy appropriately. On average, 19 contacts were provided
per participant (15 hours), starting about the same time (day 17)
as the therapists’ first contacts with the intervention group.
Continual training and support for visitors by the visitor monitor
ensured protocol adherence and human resource management.
Adding in the additional NHS speech and language therapy
received by the 18 participants who refused their allocation
meant that controls overall received an average total of 23
contacts (visitor plus usual care), almost identical to the average
of 22 contacts received by those in the intervention arm. Most
visitors prepared a rough plan for each visit based on what they
picked up about a participant’s interests, family, and job, but
generally let the sessions be patient led. The activity that
occurred most frequently was, not surprisingly, conversation.
Other activities occurred, but far less often (such as reading to
the participant; games; television, radio, music; and “other,”
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which included jigsaws, looking at photographs, going out,
making coffee).
Primary outcome
There was an overall improvement of 0.8 on the activity level
scale of the Therapy OutcomeMeasure from pre-randomisation
baseline scores taken by a speech and language therapist. This
suggests a clinically meaningful gain in functional
communication, from a baseline mean of 2.4 (“limited
communication, relies on cues and context to make basic needs
understood”) to a mean of 3.2 six months later (“consistently
able to make needs known, communicates beyond here and
now”). However a similar magnitude of improvement was seen
for both arms, with the control group starting and completing
the study with slightly lower scores.
Primary outcome analysis was conducted by comparing the
between group difference in Therapy OutcomeMeasure activity
scores at six months. The mean was slightly higher in the
intervention group and was a little less variable (table 5⇓). The
planned primary analysis, adjusted for intended stratification
factors and including deaths, favoured speech and language
therapy but was not statistically significant. The confidence
interval included the 0.5 point difference the study was powered
to detect but also included zero.
Sensitivity analyses
The primary outcome measure was further explored using
various sensitivity analyses: exclusion of deaths; extra
adjustment for baseline differences in Therapy Outcome
Measure activity and Modified Barthel Index; restricting the
analysis to per protocol groups with adjustment for baseline age
(as age was identified as predictive of outcome), Therapy
Outcome Measure activity, and Modified Barthel Index; and
restricting the analysis to per protocol groups with adjustment
for baseline age, Therapy Outcome Measure activity, and
Modified Barthel Index and excluding deaths.
As shown in figure 2⇓, the findings are robust. However the
primary analyses are adjusted, there is no suggestion of an added
benefit of speech and language therapy intervention over and
above the control social contact. In particular, exclusion of
deaths and adjustment for baseline differences both move the
estimated treatment difference to near zero and remove the
continued possibility of the targeted 0.5 point difference between
groups. This suggests evidence of absence of a treatment effect
rather than simply absence of evidence. The two per protocol
analyses give similar conclusions to those from their
intention-to-treat counterparts. This removal from analyses of
people who refused their allocation and received NHS speech
and language therapy at some point (including the 18 control
participants allocated to see only a visitor) suggests that the
protocol deviation did not cause a dilution of treatment effect.
Consideration of possible clustering due to therapist effects, by
inclusion of lead therapist or visitor as a random effect, did not
alter the analyses as estimated intra-cluster correlation
coefficients were zero in both trial arms.
Subgroup analyses
Subgroup analyses were provided for future systematic
reviewers, but there was no suggestion that the treatment effect
differed between subgroups by diagnosis or by baseline severity
of communication impairment. Diagnostic categories are not
exclusive because presenting these as “any aphasia” (which
may include dysarthria too) is more relevant to future service
delivery than “only aphasia.” Analyses used the primary analysis
method (inclusion of deaths and adjustment for intended
stratification factors but not for observed baseline imbalances).
The conclusions are similar as for the overall cohort, with wider
confidence intervals resulting from reduced sample sizes. For
completeness and visual comparison these results are included
in figure 2⇓.
Secondary outcomes
Table 5⇓ presents the summary statistics and analyses of the
secondary outcomes after adjustment for the intended
stratification criteria. All outcomemeasures present a consistent
pattern from the perspectives of different stakeholders—that is,
participants and carers. Groups were similar for all scales of the
COAST, Carer COAST, and COPE measured at six months,
and for all subscales (not shown). This means there was no
evidence of added benefit of the speech and language therapy
intervention over and above the control social contact on
participant or carer perceptions of the participant’s
communication, nor on carer perceptions of impact on
themselves in terms of their own quality of life or wellbeing.
Serious adverse events
There were no suspected adverse reactions and no unexpected
serious adverse events during the trial. Overall, 12 participants
died, six survived further strokes, and four others required
extended or repeat hospitalisation. Numbers of each of these
events were higher in the control group, but there were no
statistically significant differences between the groups in either
overall serious adverse events (odds ratio 0.42 (95% confidence
interval 0.16 to 1.1)) or death rates (odds ratio 0.48 (0.14 to
1.6)) but also low power to detect such differences. However,
given the similarity in outcome between the groups, it would
be challenging to hypothesise amechanism for increased adverse
events in either group.
Discussion
Principal findings
People with aphasia or dysarthria, who were offered well
resourced but individually tailored, best practice, speech and
language therapy in the first four months after stroke, showed
similar levels of functional communication ability at six months
as those who received visits from a non-therapist employed to
provide an unstructured social contact consisting largely of
informal conversation but no specific communication training.
Similarly, there was no added benefit for any outcome measure
reported by participants or carers, for serious adverse events,
or for any sensitivity or subgroup analysis.
Although both groups improved on the primary outcome, this
could have been due to spontaneous recovery, regression to the
mean, or general support from a therapist or visitor. Data on
resource use showed that users accepted an average of 22
contacts over 13 weeks (from therapists or visitors) of the
maximum available to them. These provide useful acceptability
data to any researchers considering providing more intensive
early intervention. The nested qualitative study reported
elsewhere helps interpret the randomised controlled trial and
resource use findings, suggesting that users value early regular
contact (with a therapist or visitor) that provides an opportunity
to practise functional communication and has a positive impact
on their confidence and mood.19
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Comparison with other studies
This is the first trial of speech and language therapy for people
with dysarthria, as none was identified in the Cochrane review15
or recent literature searches conducted for the updated clinical
guideline due out in 2012.
The recently updated Cochrane review of aphasia identified 39
trials (including this one) evaluating several different
interventions and modes of delivery and at different points in
the stroke pathway.17 It does not include an analysis of trials in
the early stage of the pathway, so this comparison is made
below.Most (19/39) of the included trials compared speech and
language therapy with no therapy. Unsurprisingly, given the
potential placebo effect, they found significant functional
communication benefits from therapy. The review’s second
comparison examined the important question of whether the
benefit remains when therapywas comparedwith “social support
or stimulation.” Of the seven included trials, only two provided
data on functional communication (ours and David et al 198228),
and no evidence of difference was found. The trial by David et
al may be more relevant for people with chronic aphasia as their
participants were between four and 432 weeks after stroke.28
The international evidence base for the acute phase of the stroke
pathway is now quite strong, as ACT NoW is the third trial to
publish in the past year. Two recent trials in Sweden and
Australia evaluated “very early” speech and language therapy
for people with aphasia (not dysarthria).29 30 They recruited
earlier than ACT NoW (around 3 days versus our 12), but they
provide different pieces of evidence about early intervention,
as they used different control comparators.
The Swedish study randomised 123 patients with ischaemic
stroke and found no evidence of difference in primary or
secondary outcomes between a control group (no contact) and
a group allocated to 21 days of 45 minutes per day of language
enrichment therapy as measured at 21 days.29 Functional and
impairment level measures were used. This is a useful trial with
which to answer queries about whether the ACT NoW
intervention was intensive enough or early enough. It found no
evidence for the effectiveness of an intensive programme of
impairment focused therapy “very early” after a stroke. This is
resonant of a UK study which found no evidence of difference
on impairment level measures for five versus two hours per
week of speech and language therapy for 12 weeks (and lower
user acceptability for the higher intensity).31 The Cochrane
review also warns of the higher dropout from high intensity
interventions across the stroke pathway.17
The Australian trial30 was designed as a pilot and randomised
only 59 people with aphasia to either daily, individually tailored,
impairment based, speech and language therapy (around 2.5
hours per week over the first three weeks) or to usual care (not
more than once a week), with functional and impairment level
outcomes measured at acute hospital discharge or four weeks.
The results suggested that, in those who could interact for up
to 30 minutes, very early intensive speech and language therapy
was feasible and might improve immediate outcomes when
compared with almost no speech and language therapy.
Methodological issues may temper their positive conclusions.
As it was a pilot study, randomisation was not stratified (such
as for severity), and the authors warned of the possible impact
of baseline imbalance favouring the intervention group,
including the measure subsequently used as the primary
outcome. Also “picture description,” a task practised at every
therapy session, was a component of the primary outcome
measure, raising the possibility of a task-specific practice effect
rather than a true difference in functional outcome. The lack of
a control group that received a similar intensity of attention
prevented discrimination between effects of speech and language
therapy or of general psychosocial benefits from regular contact.
The ACT NoW study specifically addressed this.
One other study of relevance to this discussion is the Cochrane
review of repeated task practice. Our suggestion that regular
contact with a therapist or visitor provided increased opportunity
to practise everyday communication fits with the review’s
positive findings, although they evaluated non-communication
tasks.32
Strengths and weaknesses of ACT NoW
Concerns about the feasibility of a randomised controlled trial
of this complex intervention for a heterogeneous clinical
population proved unfounded. A robust evaluation was
successfully completed with low risk of bias, valid and reliable
outcomemeasurement, and results generalisable to international
stroke services. The involvement of service users as research
partners throughout the process from design to dissemination
has greatly improved this study. The use of mixed methods,
nesting a qualitative study within the randomised controlled
trial,18 19 added richness to the interpretation of the randomised
controlled trial results and is recommended good practice.33
A smaller than expected proportion of patients admitted to
hospital with stroke was deemed eligible, but exclusions were
prospectively checked and were justifiable (such as false
positives from screening). It would be contradictory to argue
that the intervention would have been more effective for those
patients who were excluded by practising therapists as being
unlikely to benefit. Concerns that different clinical populations
(people with aphasia versus dysarthria) were inappropriately
subjected to a “one size fits all” intervention can be relieved by
referring to the detailed description of the individualised
approach taken to assessment and intervention, and the
presentation of planned subgroup analyses for aphasia and
dysarthria.18 Although it is theoretically possible that small
differences within subgroups were missed, our data do not
suggest different effect sizes by impairment subgroup. Although
18 people refused the control allocation and received some usual
care speech and language therapy, we know from our additional
per protocol analysis that this did not dilute any effect. It was
highly predictable that people would prefer contact labelled
“therapy” rather than the control. It follows that being in a trial
further raises expectations as participants are offered a 50:50
chance of an enhanced package of that current service.
A strength of ACT NoW was the move away from traditional
surrogate measures of impairments towards using measures of
activity and participation level as outcomes, including patient
reported and patient centred outcomes. The use of impairment
measures (as outcomes rather than as baseline descriptors)
confuses process and outcome measures. An outcome measure
needs to capture the desired end point rather than describing the
intervention delivered—that is, even if an intervention has a
strong impairment focus, it needs to prove itself by producing
a meaningful impact.
There may be divided opinion over whether attention control
was the most suitable choice for this study. Uncertainty over
the relative contribution of natural recovery versus the early,
regular attention provided by therapists or visitors, would have
been eliminated by a control group of no contact. However, if
therapy had proved more effective, it would remain unknown
whether the active mechanism was the therapy or the
psychosocial effect of providing attention. An alternative control
would have been usual care. Assuming an effect along a
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continuum for therapy per se as opposed to attention, with usual
care theoretically in between the two ACT NoW groups, our
finding of no difference between the two extremes would be
replicated when comparing the extreme and midpoint.
Limitations were the absence of descriptive socioeconomic data
and the exclusion of people unable to communicate in the
English language (as services did not have provision for
bilingual speech and language therapists, and the therapists
believed that translation or interpretation services were not
appropriate for aphasia).
Implications for clinical practice
When the full ACT NoW evidence18 19 is considered within the
context of other recent trials and reviews,29 17 it is clear that early
communication services should be reorganised. Ineffective
treatment approaches should be replaced with more promising
ones and the latter should be evaluated. There is no suggestion
that speech and language therapists should be removed from
the early stage of the stroke pathway. The approaches requiring
replacement are one to one, impairment focused therapy18 29 31
and detailed cognitive neuropsychological assessment in the
first few months after stroke.18 The latter was a core component
of the ACT NoW intervention and provided only to those
allocated to the therapy group. Therapists must continue to
distinguish between aphasia, dysarthria, and apraxia of speech
and include assessment of the activity restrictions resulting from
these often coexisting impairments (such as the
pre-randomisation assessment).
Extreme caution is required to avoid over-extrapolation of the
evidence leading to damage to vulnerable services for people
with high unmet need but potential to benefit. People with
communication problems after stroke will continue to need
support. Replacement approaches are required, and some
services will welcome the justification to develop their activity
level and social participatory approaches. These seem to have
been used less often in ACT NoW, along with training with a
conversation partner and group work. ACT NoW shows that
users value and are willing to use support provided early,
frequently, and flexibly regardless of whether it is from a
therapist or a visitor,18 so skill mix could be explored to make
use of less qualified assistants.
ACT NoW supports a reorganisation of early communication
therapy but not a withdrawal of speech and language therapists
from the early stage of the stroke pathway. In addition to
providing communication therapy, speech and language
therapists play an important role in the management of
dysphagia (swallowing) that starts during the hyperacute phase
and was not evaluated within the trial. Service reorganisation
for communication problems could include, for example, a
stepped care model, similar to that recently recommended by
the Stroke Improvement Programme for psychological support.34
Future research
In addition to a trial of a reorganised, early stepped care model
of communication therapy versus usual care, future research
should evaluate specific interventions that show promise, such
as training with a conversation partner and constraint induced
aphasia therapy. Certain populations have been badly neglected
in previous research such as people with dysarthria, people who
were not fluent in English before their stroke, and people living
with persisting communication problems years and decades
after their stroke. It is important to develop evidence specific
to the different stages of the stroke pathway, distinguishing
between early and later needs and services. The ACTNoWbest
practice intervention may have been provided too early in the
stroke pathway. The effectiveness of later provision by speech
and language therapists remains an important clinical question
warranting a clinical trial, likely to be addressed by the recent
NIHR Health Technology Assessment Programme’s
commissioning brief for persistent speech and language
problems.
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What is already known on this topic?
Many people survive their stroke with lifelong restrictions on their ability to communicate because of impaired speech (dysarthria) or
language (aphasia)
Despite a firm consensus that speech and language therapy is beneficial after a stroke, clinical effectiveness remains unknown, cost
effectiveness untested within a trial, and service provision is highly variable and often poorly resourced
Early intervention by speech and language therapists may improve functional communication and quality of life for survivors and carers
What this study adds
Providing more frequent contacts with speech and language therapists or with non-therapist visitors in the first four months after stroke
is feasible and acceptable to service users with impaired communication
Functional communication improved over six months for both groups, plausibly due to natural recovery and repeated practice of everyday
communication with a therapist or visitor
There were no added benefits of contact with a qualified therapist in the first four months after stroke compared with a non-therapist
consent was obtained from each participant before randomisation.
Site-specific and NHS Trust research and development approvals were
also obtained.
Data sharing: Technical appendix, statistical code, and dataset available
from the trial statistician at andy.vail@manchester.ac.uk. Data sharing
consent was not obtained, but the presented data are anonymised and
risk of identification is low.
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Tables
Table 1| External validity of eligible stroke patients who participated in study compared with those who declined. Values are numbers
(percentages) of patients unless stated otherwise
Eligible but declined (n=272)Participants (n=170)Characteristic
145/270 (54)95 (56)Male
72 (31–95)70 (32–97)Mean (range) age in years
238/247 (88)153 (90)Aphasia,* total:
131 (55)98 (64)Severe
104/239 (44)66 (39)Dysarthria,* total:
54 (52)35 (53)Severe
Severe overall communication problem:
151/245 (62)116 (68)Impairment level
139/235 (59)87 (51)Activity level
135/252 (54)87 (51)Dysphagia
*Measured at the level of impairment.
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Table 2| Baseline characteristics of 170 adults with stroke who participated in comparison of speech and language therapy (intervention)
and unstructured social contact (control). Values are numbers (percentages) of participants unless stated otherwise
Intervention (n=85)Control (n=85)Characteristic
70 (32–97)70 (40–92)Mean (range) age in years
49 (58)46 (54)Male
Diagnosis:
51 (60)53 (62)Aphasia only
9 (11)8 (9)Dysarthria only
25 (29)24 (28)Both
Mean (SD) impairment rating:
1.9 (1.2)
(n=76)
1.9 (1.1)
(n=77)
Aphasia
2.2 (1.2)
(n=34)
2.5 (1.1)
(n=32)
Dysarthria
58 (68)58 (68)Either impairment severe*
Communication activity rating:
2.3 (1.3)2.2 (1.2)Mean (SD)
40 (47)47 (55)Severe
41 (48)47 (55)Dysphagia present
Overall disability score†:
12.7 (7.2)10.7 (7.3)Mean (SD)
36 (42)22 (26)Mild (score 18–20)
17 (20)22 (26)Moderate (score 11–17)
32 (38)41 (48)Severe (score 0–10)
*Stratification factor in the randomisation routine. Severe=score of 0–2 on communication activity scale of the Therapy Outcome Measure.
†Based on the 10 item modified Barthel Index, which gives a score out of 20.
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Table 3| Details of delivery of the six therapy components among the 81 adults with stroke who received the speech and language therapy
intervention. Values are percentages (numbers) of participants
Therapy component
Group or subgroup Carer contact (n=73)Direct contactIndirect contactCommunication materialsInformationAssessment
96 (70/73)100 (81)84 (68)54 (44)78 (63)100 (81)All (n=81)
Diagnosis:
97 (62/64)100 (72)83 (60)57 (41)79 (57)100 (72)Aphasia (n=72)
93 (27/29)100 (33)85 (28)39 (13)78 (26)100 (33)Dysarthria (n=33)
Communication problem:
97 (33/34)100 (37)81 (30)65 (24)86 (32)100 (37)Severe (n=37)
95 (37/39)100 (44)86 (38)45 (20)70 (31)100 (44)Mild or moderate (n=44)
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Table 4| Detailed breakdown of the specific activities included in the “direct contact” component of the speech and language therapy
received by the 81 adults with stroke in the intervention group. Values are percentages (numbers) of participants
Specific activities
Group or subgroup Other*Work set for review periodGoal settingConversation practiceFunctionalImpairment
85 (69)30 (24)86 (70)60 (49)67 (54)93 (75)All (n=81)
Diagnosis:
85 (61)32 (23)85 (61)60 (43)65 (47)92 (66)Aphasia (n=72)
85 (28)27 (9)85 (28)61 (20)61 (20)97 (32)Dysarthria (n=33)
Communication problem:
84 (31)24 (9)81 (30)65 (24)70 (26)92 (34)Severe (n=37)
86 (38)34 (15)91 (40)57 (25)64 (28)93 (41)Mild or moderate (n=44)
*Other activities such as counselling, computer use, joint therapy.
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Table 5| Primary and secondary outcomes (at six months) for adults with stroke who participated in comparison of speech and language
therapy (intervention) and unstructured social contact (control). All outcomes are adjusted for the intended stratification criteria: site,
diagnosis and severity of impairment at baseline. Values are means (standard deviations) unless stated otherwise
Difference
InterventionControlScale P valueMean (95% CI)
0.270.25 (–0.19 to 0.69)3.3 (1.4)
(n=81)
3.0 (1.6)
(n=72)
TOM
0.85–1 (–7 to 6)71 (18)
(n=67)
73 (18)
(n=50)
COAST
0.910 (–7 to 7)62 (21)
(n=70)
62 (18)
(n=59)
Carer COAST
COPE:
0.340.6 (–0.6 to 1.9)24 (3.5)
(n=67)
23 (3.2)
(n=58)
Negative
0.96–0.0 (–0.9 to 0.9)13 (2.5)
(n=68)
13 (2.4)
(n=57)
Positive
0.470.4 (–0.7 to 1.6)12 (3.3)
(n=65)
11 (3.2)
(n=57)
Support
TOM = Therapy Outcome Measure, COAST = Communication Outcomes After Stroke scale, COPE = Carers of Older People in Europe.
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Figures
Fig 1 Participant flow through study
Fig 2 Sensitivity and subgroup analyses for the primary outcome
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